Seropositivity of Hepatitis B and Hepatitis C Virus and Its Coinfection: A Hospital Based Study
DOI:
https://doi.org/10.21276/apalm.3806Keywords:
serology, ELISA, hepatitis, coinfectionAbstract
Background: The spectrum of Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infection ranges from self-limiting to acute fulminant to chronic hepatitis. The Laboratory diagnosis of HBV is by detection of various sero-markers and HCV is by indirect and direct tests. HBV and HCV have same modes of transmission and can be co-transmitted simultaneously or by superinfection with significant clinical implications. Hence, this study is undertaken to estimate seroprevalence of HBV and HCV and its coinfection among general population attending hospital.
Methods: This retrospective observational study was carried out from Jan to Dec 2022 on OPD and IPD specimens tested for HBV and HCV screening by HBsAg ELISA and anti-HCV ELISA. Seroprevalence was calculated as proportion of samples positive amongst tested and Chi Square test was used for statistical analysis.
Result: Out of 36873 samples tested for HBV ELISA, 747 were positive with 2.0% seroprevalence, and 36500 samples tested for HCV ELISA, 361 were reactive with 0.99% seroprevalence. Male to female ratio for HBV was 2:1, HCV 1.2:1 and for coinfection 4.6:1. The most affected age group was 18-40 years. There is a significant difference in sample seropositivity between OPD and IPD. In co-infection maximum positivity was from Nephrology, followed by GI medicine.
Conclusion: Emphasis on awareness about preventive measures, and curtailing high risk behaviours among young adults should be stressed. Effective HBV Vaccination coverage with more data on HBV and HCV coinfection needs to be obtained.
References
1. Patil SR, Ghorpade MV, Patil SS, Pawar SK, Mohite ST. Seroprevalence of Hepatitis-B surface antigen among the patients reporting at tertiary care Hospital from India. Banglad J Med Sci. 2016;15(3):455–459.
2. Khudur Al-Nassary MS, Mahdi BM. Study of Hepatitis C Virus Detection Assays. Ann Med Surg (Lond). 2018;36:47-50.
3. Kumar A, Mahajan H, Chaturvedi S, Kumar A, Kumar S, Sahoo GC, et al. Hepatitis C virus seroprevalence among patients enrolled at the opioid substitution therapy center in Bihar: A cross-sectional study. PLoS One. 2023;18:e0287333.
4. Singh B, Jayant S, Dehariya R, Poddar A, Bajpai T. Seroprevalence of Hepatitis B Virus infection in patients visiting a tertiary care hospital in Central India. Int J Heal Clin Res. 2021;4:130–132.
5. Kulkarni S, Chillarge C. Seroprevalence of hepatitis b surface antigen infection among outpatients attending a tertiary care centre. Indian J Microbiol Res. 2020;7:270-272.
6. Sood S, Malvankar S. Seroprevalence of hepatitis B surface antigen, antibodies to the hepatitis C virus, and human immunodeficiency virus in a hospital-based population in Jaipur, Rajasthan. Indian J Community Med. 2010;35:165-169.
7. Quadri SA, Dadapeer HJ, Arifulla KM, Khan N. Prevalence of Hepatitis B Surface Antigen in hospital based population in. Al Ameen J Med Sci. 2013;6:180–182.
8. Naqshbandi I, Qadri S, Yasmeen N, Bashir N. Seroprevalence and risk factors of Hepatitis B virus infection among general population of Srinagar Kashmir. Int J of Contemporary Med Res. 2016;3:1050–1054.
9. Gupta E, Bajpai M, Choudhary A. Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays. Asian J Transfus Sci. 2014;8:19-25.
10. Goel A, Seguy N, Aggarwal R. Burden of hepatitis C virus infection in India: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2019;34:321-329.
11. Parimala TV. Seroprevalence of Anti HCV Antibodies in a Tertiary Care Hospital in Tumkuru, India. Int J Curr Microbiol App Sci. 2016;5(10):992-996.
12. Rahaman J, Sengupta M, Barik G, Sarkar S, Sarkar R, Sengupta M. Seroprevalence and Co-infection of Hepatitis B and Hepatitis C among Patients in a Tertiary Care Hospital in Eastern India. J Assoc Physicians India. 2019 Sep;67(9):27-29.
13. Kumar M, Verma RK, Singh M, Nirjhar S, Chaudhary R. Seroprevalence of HCV infection at a tertiary care hospital, western Uttar Pradesh, India. Int J of Research and Review. 2019;6:1-5.
14. Patil SR, Patil SS, Shinde RV, Karande GS, Patil HV, Mane PM. Seropositivity and Risk Factors of Hepatitis B in Maharashtra, India. J of Krishna Inst of Med Sci Univ. 2016;5:82-90.
15. Bhaumik P, Kumar Sil S, Debnath K, Bhattacharjee S. Prevalence of Hepatitis B in Tripura: A Community Based Study. J of Evidence Based Med & Hlthcare. 2014;1:2156–2161.
16. Conners EE, Panagiotakopoulos L, Hofmeister MG, Spradling PR, Hagan LM, Harris AM, et al. Screening and testing for hepatitis B Virus Infection: CDC recommendations - United States, 2023. MMWR Recomm Rep. 2023;72:1–25.
17. Panagiotakopoulos L, Sandul AL, et al. CDC Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children — United States, 2023. MMWR Recomm Rep. 2023;72:1–19.
18. Desikan P, Khan Z. Prevalence of hepatitis B and hepatitis C virus co-infection in India: A systematic review and meta-analysis. Indian J Med Microbiol. 2017;35:332-339.
19. Agarwal L, Singh AK, Agarwal A, Singh RP. Incidental detection of hepatitis B and C viruses and their coinfection in a hospital-based general population in tertiary care hospital of Uttar Pradesh. J Family Med Prim Care. 2018;7:157-161.
20. Saravanan S, Velu V, Nandakumar S, Madhavan V, Shanmugasundaram U, Murugavel KG, et al. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease. J Microbiol Immunol Infect. 2009;42:122–128.
21. Malhotra R, Soin D, Grover P, Galhotra S, Khutan H, Kaur N. Hepatitis B virus and hepatitis C virus co-infection in hemodialysis patients: A retrospective study from a tertiary care hospital of North India. J Nat Sci Biol Med. 2016 Jan-Jun;7(1):72-4.
22. Brown R, Goulder P and Matthews PC. Sexual Dimorphism in Chronic Hepatitis B Virus (HBV) Infection: Evidence to Inform Elimination Efforts. Wellcome Open Research 2022, 7:32.
23. Liu WC, Liu QY. Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol. 2014;20(20):6252-61.
24. Jamma S, Hussain G, Lau DT. Current concepts of HBV/HCV coinfection: coexistence, but not necessarily in harmony. Curr Hepat Rep. 2010;9:260–269.
25. Mavilia MG, Wu GY. HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation. J Clin Transl Hepatol. 2018;6(3):296-305.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Vaishali Solanke-Surase, Devika Thorat, Shashir W. Wanjare, Ranjana N. Thate, Chaya A. Kumar
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
How to Cite
